Prior to founding Evolytical with a focus on research, strategy, asset allocation, replication strategies and deep alpha private markets, Phillip was the Chief Investment Officer at multi-family office Filament, LLC where he was responsible for overseeing investment strategy, asset allocation, research, and manager and product selection processes for $1.8 billion in assets under management across traditional and alternative asset classes. Phillip served as Chair of the firm’s Investment Committee and has over 20 years of experience in investment research, strategy, and execution, including early roles in research and trading at Russell Investments and